Fairchem Organics Ltd · NSE:FAIRCHEMOR
Fairchem Organics — Q1 FY2023 Earnings Presentation
14 slides from Fairchem Organics's earnings presentation, Aug 12, 2022
Slide 1: Earnings Presentation Q1-FY23
Earnings Presentation Q1-FY23
Slide 2: Company at a Glance
Company at a Glance Well entrenched Forward integration to make Customer value added products such as Relationships in Promoted by Fairfax Tocopherols 50%, Sterols 90% Long lasting Pan India from current intermediate high growth India Holdings and Raw Material sourcing Nutraceuticals stream, Methyl
Slide 3: Company Overview
Company Overview • Fairchem Organics Ltd. (Fairchem) is engaged in the business of manufacturing of Oleo Chemicals and Nutraceuticals, since the last 25 years. Revenue & EBITDA Margin (In Mn) • The company’s key oleo chemical products include Dimer Acid, Linoleic Acid, Palmitic Acid, 6,432 Monomer A
Slide 4: Fairchem's Competitive Advantage
Fairchem’s Competitive Advantage Major Player in the Indian Oleo Chemical Market Using Renewable Resources • Processing waste from edible oil refining process to produce high value oleo chemicals giving it price advantage • Enjoy Leadership Position in the industry due to barriers to entry • Focus o
Slide 5: Financial Governance Standards
Financial Governance Standards Invest for long term growth value creation Always be adequately capitalized Not overleverage the balance sheet Secure sources of sustainable raw material supply Invest in backward and forward integration Transparent communications with all the stakeholders Low volatili
Slide 6: Key Financial Highlights
® FAIRCHEM Key Financial Highlights
Slide 7: Q1-FY23 Financial & Operational Highlights
Q1-FY23 Financial & Operational Highlights Q1-FY23 Financial Performance • EBITDA margins improved during the quarter by containing raw materials costs vis-a-vis realisations from sales. INR 2,251 Mn INR 400 Mn 17.77% • Improvement in volumes were due to higher capacity Revenue from EBITDA EBITDA Ma
Slide 8: Quarterly Financial Performance
Quarterly Financial Performance PARTICULARS (INR Mn) Q1-FY23 Q1-FY22 Y-O-Y Q4-FY22 Q-O-Q Revenue from Operations 2,251 1,391 61.8% 1,776 26.7% Total Expenses 1,851 1,063 74.1% 1,589 16.5% EBITDA 400 328 22.0% 187 NA EBITDA Margins (%) 17.77% 23.58% (581) Bps 10.53% 724 Bps Other Income 3 4 (25.0)% 1
Slide 9: Historical Income Statement
Historical Income Statement PARTICULARS (INR Mn) FY20 FY21 FY22 Q1-FY23 Revenue from Operations 3,065 3,966 6,432 2,251 Total Expenses 2,581 3,279 5,383 1,851 EBITDA 484 687 1,049 400 EBITDA Margins (%) 15.79% 17.32% 16.31% 17.77% Other Income 66 3 3 3 Depreciation 60 66 71 19 Finance Cost 66 68 69
Slide 10: Historical Balance Sheet
Historical Balance Sheet ASSETS FY20 FY21 FY22 EQUITY AND LIABILITIES FY20 FY21 FY22 Non-Current Assets EQUITY Property, Plant and Equipment 1,219 1,220 1,363 Equity Share Capital 130 130 130 Instruments entirely equity in nature Capital work-in-progress 94 295 420 Other Equity 1,137 1,557 2,191 Rig
Slide 11: Historical Cash Flow Statement
Historical Cash Flow Statement PARTICULARS (INR Mn) FY20 FY21 FY22 Cash and Cash Equivalents at Beginning of the year 0.2 0.3 0.3 Cash Flow From Operating Activities 312 394 405 Cash Flow from Investing Activities (239) (228) (342) Cash Flow From Financing Activities (73) (166) (63) Net Inc./(Dec.)
Slide 12: Key Financial Highlights
Key Financial Highlights Revenue (In Mn) EBITDA (In Mn) & EBITDA Margin (%) PAT (In Mn) & PAT Margin (%) 5 Year CAGR - 26% 5 Year CAGR - 35% 5 Year CAGR - 49% 6,432 1,049 679 3,966 687 425 3,065 484 347 2,499 400 270 2,428 2,251 338 361 194 215 17.32% 16.31% 17.77% 11.32% 10.72% 10.56% 12.00% 13.92%
Slide 13: Capital Market Data
Capital Market Data Stock Market Performance (as on 30th June, 2022) Dividend Percentage 60% 130.00% 50% 40% 30% 20% 10% 0% -10% 35.00% 25.00% -20% 15.00% 15.00% -30% Jul-21 Aug-21 Sep-21 Oct-21 Nov-21 Dec-21 Jan-22 Feb-22 Mar-22 Apr-22 May-22 Jun-22 Fairchem Sensex FY18 FY19 FY20 FY21 FY22 Price Da
Slide 14: Disclaimer
Disclaimer Fairchem Organics Limited Disclaimer: The information contained in this presentation is only current as of its date. All actions and statements made herein or otherwise shall be subject to the applicable laws and regulations as amended from time to time. There is no representation that al